minimally invasive screw type tooth replacement
- Conditions
- Health Condition 1: K069- Disorder of gingiva and edentulousalveolar ridge, unspecified
- Registration Number
- CTRI/2019/09/021168
- Lead Sponsor
- DR PSG PRAKASH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
1)Patients with age ranging from 19 -50 years.
2)Patients not contraindicated for periodontal surgical procedures.
3)Patients who have given written and verbal informed consent for the study.
4)Isolated edentulous sites from Maxillary anteriors and premolars with single rooted edentulous sites were taken for the study.
5)The choice of patient selection for socket Augmented group are the patients with a previous history of extraction followed by socket augmentation with Bio active synthetic glass bone graft and left to heal for a minimum of six months at the time of evaluation.
6)The choice of patient selection for Non Augmented group are , the patients with a history of previous extraction followed by spontaneous healing for a minimum of 6 months at the time of evaluation.
7)The patients who presented with a single edentulous site having a minimum bone height >= 9mm and bone width >= 4mm evaluated through CBCT bounded on either side by healthy natural teeth.
1)Chronic therapy under non-steroidal anti-inflammatory drugs, Bisphosphonates and Corticosteroids.
2)Current smokers ( >10 cigarettes per day).
3)Evidence of loss of any bony wall
at the time of extraction or during socket augmentation.
4)The extractions other than the following reasons will be excluded:
•Extraction of teeth due to Failure of endodontic treatment.
•Extraction due to Fracture of tooth due to trauma and the fracture line extending subgingivally which cannot be restored endodontically.
•Tooth with poor prognosis (grossly decayed).
•Residual root stumps.
5)Pregnancy.
6)Untreated periodontitis.
7)Para-functional habits.
8)Immunosuppressed or immunocompromised patients.
9)Active infection or severe inflammation at the implant placement site.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method